Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BI 836880 |
Synonyms | |
Therapy Description |
BI 836880 is a nanobody that binds to both VEGF and ANGPT2, which inhibits downstream signaling, potentially resulting in antitumor activity (PMID: 37140602). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BI 836880 | BI836880|BI-836880|Bi-specific Anti-VEGF/Ang2 Nanobody BI 836880 | VEGF Antibody 12 | BI 836880 is a nanobody that binds to both VEGF and ANGPT2, which inhibits downstream signaling, potentially resulting in antitumor activity (PMID: 37140602). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|